Literature DB >> 4797728

Immunological features in a case of subacute sclerosing panencephalitis treated with transfer factor.

B Vandvik, S S Froland, H M Hoyeraal, R Stien, M Degré.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4797728     DOI: 10.1111/j.1365-3083.1973.tb02045.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


× No keyword cloud information.
  7 in total

Review 1.  Clinical applications of the continuous flow blood separator machine.

Authors:  C J Oon; J R Hobbs
Journal:  Clin Exp Immunol       Date:  1975-04       Impact factor: 4.330

2.  Transfer factor therapy in ataxia--telangiectasia.

Authors:  A I Berkel; F Ersoy; L B Epstein; L E Spitler
Journal:  Clin Exp Immunol       Date:  1977-09       Impact factor: 4.330

3.  Letter: Interferon in serum and cerebrospinal fluid in subacute sclerosing panencephalitis.

Authors:  J H Joncas; L R Robillard; A Boudreault; M Leyritz; B J McLaughlin
Journal:  Can Med Assoc J       Date:  1976-08-21       Impact factor: 8.262

4.  Editorial: Transfer factor.

Authors: 
Journal:  Br Med J       Date:  1974-05-25

5.  Cellular immunity in SSPE patients.

Authors:  H W Kreth; Y M Kaeckell; V ter Meulen
Journal:  Med Microbiol Immunol       Date:  1974       Impact factor: 3.402

6.  Long-term survival of a case of subacute sclerosing panencephalitis.

Authors:  C R Barraclough
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-05       Impact factor: 10.154

7.  Transfer factor therapy in patients with subacute sclerosing panencephalitis.

Authors:  Y M Käckell; P J Grob; W H Kreth; R Kibler; V Meulen
Journal:  J Neurol       Date:  1975-12-02       Impact factor: 4.849

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.